Soodeh Razeghi Jahromi1, Maryam Abolhasani2, Zeinab Ghorbani3,4, Solmaz Sadre-Jahani1, Zahra Alizadeh2, Mohammad Talebpour5, Alipasha Meysamie6, Mansoureh Togha7. 1. Department of Clinical Nutrition and Dietetics, Faculty of Nutrition and Food Technology, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 2. Sports Medicine Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran. 3. Headache Department, Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran. 4. School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran. 5. Surgery Department, Laparoscopic Surgical Ward, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran. 6. Community and Preventive Medicine Department, Medical Faculty, Tehran University of Medical Sciences, Tehran, Iran. 7. Headache Department, Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medial Sciences, Tehran, Iran. toghae@sina.tums.ac.ir.
Abstract
INTRODUCTION: There is evidence that substantial weight loss through bariatric surgery (BS) may result in short-term improvement of migraine severity. However, it still remains to be seen whether smaller amounts of weight loss have a similar effect on migraine headache. This study has been designed to compare the effects of weight reduction through BS and non-surgical modifications. MATERIALS AND METHODS: Migraine characteristics were assessed at 1 month before (T0), 1 month (T1), and 6 months (T2) after BS (vertical sleeve gastrectomy (VSG) (n = 25) or behavioral therapy (BT) (n = 26) in obese women (aged 18-60 years) with migraine headache. Migraine was diagnosed using the International Classification of Headache Disorders (ICHDIIβ) criteria. RESULTS: There was significant reduction in the visual analog scale (VAS) from the baseline to T1 and T2 in both groups. The number of migraine-free days showed a significant increase within each group (p < 0.001). The BS group had a significant reduction in attack duration (p < 0.001) while there were no changes observed within the BT group. Following the adjustment of ANCOVA models for baseline values of migraine characteristics, age, changes in weight, BMI, body fat, and fat-free mass from T0 to T2, the BS group showed statistically significant lower VAS and duration of migraine attacks and a significantly higher number of migraine-free days than the BT group at T1 and T2 (p ≤ 0.028). CONCLUSION: Our results indicated that far before significant weight reduction after BS (VSG), there was marked alleviation in the severity and duration of migraine and a significant increase in the number of migraine-free days in obese female migraineurs. However, the effects in the BT group were not comparable with the effects in the BS group.
INTRODUCTION: There is evidence that substantial weight loss through bariatric surgery (BS) may result in short-term improvement of migraine severity. However, it still remains to be seen whether smaller amounts of weight loss have a similar effect on migraine headache. This study has been designed to compare the effects of weight reduction through BS and non-surgical modifications. MATERIALS AND METHODS:Migraine characteristics were assessed at 1 month before (T0), 1 month (T1), and 6 months (T2) after BS (vertical sleeve gastrectomy (VSG) (n = 25) or behavioral therapy (BT) (n = 26) in obese women (aged 18-60 years) with migraine headache. Migraine was diagnosed using the International Classification of Headache Disorders (ICHDIIβ) criteria. RESULTS: There was significant reduction in the visual analog scale (VAS) from the baseline to T1 and T2 in both groups. The number of migraine-free days showed a significant increase within each group (p < 0.001). The BS group had a significant reduction in attack duration (p < 0.001) while there were no changes observed within the BT group. Following the adjustment of ANCOVA models for baseline values of migraine characteristics, age, changes in weight, BMI, body fat, and fat-free mass from T0 to T2, the BS group showed statistically significant lower VAS and duration of migraine attacks and a significantly higher number of migraine-free days than the BT group at T1 and T2 (p ≤ 0.028). CONCLUSION: Our results indicated that far before significant weight reduction after BS (VSG), there was marked alleviation in the severity and duration of migraine and a significant increase in the number of migraine-free days in obese female migraineurs. However, the effects in the BT group were not comparable with the effects in the BS group.
Authors: A Verrotti; S Agostinelli; C D'Egidio; A Di Fonzo; M Carotenuto; P Parisi; M Esposito; E Tozzi; V Belcastro; A Mohn; P A Battistella Journal: Eur J Neurol Date: 2012-05-29 Impact factor: 6.089
Authors: V Novack; L Fuchs; L Lantsberg; S Kama; U Lahoud; A Horev; N Loewenthal; G Ifergane Journal: Cephalalgia Date: 2011-06-23 Impact factor: 6.292
Authors: Francesco Rubino; Michel Gagner; Paolo Gentileschi; Subhash Kini; Shoji Fukuyama; John Feng; Ed Diamond Journal: Ann Surg Date: 2004-08 Impact factor: 12.969
Authors: Samantha G Farris; J Graham Thomas; Ana M Abrantes; Richard B Lipton; Jelena Pavlovic; Todd A Smitherman; Megan B Irby; Donald B Penzien; Julie Roth; Kevin C O'Leary; Dale S Bond Journal: Cephalalgia Date: 2017-12-13 Impact factor: 6.292
Authors: Jerry T Dang; Jeremy K H Lee; Janice Y Kung; Noah J Switzer; Shahzeer Karmali; Daniel W Birch Journal: Obes Surg Date: 2020-03 Impact factor: 4.129
Authors: Dale S Bond; J Graham Thomas; Richard B Lipton; Julie Roth; Jelena M Pavlovic; Lucille Rathier; Kevin C O'Leary; E Whitney Evans; Rena R Wing Journal: Obesity (Silver Spring) Date: 2017-11-27 Impact factor: 5.002